Metoclopramide versus chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs

BMJ ◽  
1985 ◽  
Vol 290 (6476) ◽  
pp. 1213-1213
Author(s):  
D Cunningham ◽  
M Soukop
Keyword(s):  
Cytotoxic Drugs ◽  
Nausea And Vomiting

▾ Ondansetron to prevent chemotherapy-induced vomiting

1992 ◽  
Vol 30 (6) ◽  
pp. 21-23
Keyword(s):  
Cytotoxic Drugs ◽  
Nausea And Vomiting ◽  
Toxic Effects ◽  
New Type

Nausea and vomiting are very common within a few hours of administration of cytotoxic drugs, and may be severe enough to interrupt treatment or interfere with nutrition. The resulting dehydration may exacerbate toxic effects of the drugs. Ondansetron (Zofran – Glaxo) is an important new type of drug for the prevention of vomiting and nausea induced by chemotherapy and radiotherapy.

scholarly journals Metoclopramide versus chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs

BMJ ◽  
1985 ◽  
Vol 290 (6476) ◽  
pp. 1212-1213
Author(s):  
S G Allan ◽  
E J Bayliss ◽  
P S Warrington ◽  
R C F Leonard
Keyword(s):  
Cytotoxic Drugs ◽  
Nausea And Vomiting

Therapy-related issues: malignant diseases and immunosuppression

2017 ◽  
Author(s):  
Philip Wiffen ◽  
Marc Mitchell ◽  
Melanie Snelling ◽  
Nicola Stoner
Keyword(s):  
Malignant Disease ◽  
Intrathecal Administration ◽  
Cytotoxic Drugs ◽  
Nausea And Vomiting ◽  
British National Formulary ◽  
National Formulary ◽  
Malignant Diseases ◽  
Clinical Screening ◽  
Clinical Pharmacists

This chapter outlines information relevant to clinical pharmacists related to malignant disease and immunosuppression and is loosely based on the British National Formulary, Chapter 8. In particular, this chapter covers administration and handling of cytotoxic drugs, clinical screening of chemotherapy prescriptions, chemotherapy dosing and toxicity, antiemetics for chemotherapy-induced nausea and vomiting, extravasation, and intrathecal administration of chemotherapy.

Therapy-related issues: malignant disease and immunosuppression

2012 ◽  
Author(s):  
Philip Wiffen ◽  
Marc Mitchell ◽  
Melanie Snelling ◽  
Nicola Stoner
Keyword(s):  
Malignant Disease ◽  
Cytotoxic Drugs ◽  
Adult Patients ◽  
Nausea And Vomiting ◽  
Clinical Screening ◽  
Paediatric Patients

Policy for the administration and handling of cytotoxic drugs 466Clinical screening of chemotherapy prescriptions 470Chemotherapy dosing 474Antiemetics for the prophylaxis of chemotherapy-induced nausea and vomiting 478Principles of extravasation 486Extravasation of chemotherapy in adult patients 488Extravasation of chemotherapy in paediatric patients ...

Domperidone: an alternative to metoclopramide

1988 ◽  
Vol 26 (15) ◽  
pp. 59-60
Keyword(s):  
Dopamine Receptors ◽  
Gastrointestinal Motility ◽  
Ventricular Arrhythmias ◽  
Cytotoxic Drugs ◽  
Nausea And Vomiting ◽  
Central Control ◽  
Acute Nausea ◽  
Chemoreceptor Trigger Zone ◽  
Trigger Zone

The anti-emetic drug domperidone (Motilium - Janssen) was introduced in 1982.1 Like metoclopramide the drug blocks dopamine receptors in the medullary chemoreceptor trigger zone, thereby influencing the central control of nausea and vomiting, and in the gut to increase gastrointestinal motility.2 Parenteral domperidone which was used to prevent vomiting caused by cytotoxic drugs or postoperatively was withdrawn in 1984 because ventricular arrhythmias had followed high intravenous doses.3,4 Oral and rectal domperidone continue to be promoted, especially since the arrival of a second brand (Evoxin - Sterling). The tablets and suppositories are licensed ‘for the treatment of acute nausea and vomiting of any aetiology, in adults’ - a remarkably broad indication. The suppositories are also for children receiving cytotoxic drugs or radiotherapy.

Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy

1984 ◽  
Vol 22 (3) ◽  
pp. 9-11
Keyword(s):  
Cancer Chemotherapy ◽  
Cytotoxic Drugs ◽  
Nausea And Vomiting ◽  
High Dose

Nausea and vomiting caused by cytotoxic drugs often resist anti-emetics in conventional doses.1,2 Nabilone and high-dose metoclopramide are two new preparations specifically for the treatment of vomiting induced by cancer chemotherapy. We have recently discussed domperidone which is also used for this purpose.3

scholarly journals Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs.

BMJ ◽  
1985 ◽  
Vol 290 (6468) ◽  
pp. 604-605 ◽  
Author(s):  
D Cunningham ◽  
M Soukop ◽  
N L Gilchrist ◽  
G J Forrest ◽  
A Hepplestone ◽  
...  
Keyword(s):  
Randomised Trial ◽  
Cytotoxic Drugs ◽  
Nausea And Vomiting ◽  
High Dose

Guidelines Target Postop Nausea and Vomiting

2007 ◽  
Vol 41 (1) ◽  
pp. 8
Author(s):  
SHERRY BOSCHERT
Keyword(s):  
Nausea And Vomiting
Sign in / Sign up

Export Citation Format

Share Document